Clinical Trials Browser

Phase 1/2 × NIH × Immunotherapy, Adoptive × Clear all

NCT01239368 2019-12-10

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Phase 1/2 Terminated

34 enrolled 17 charts

Multiple Myeloma